On March 28, the Food and Drug Administration approved Pluvicto, a new radiation agent able to treat patients with prostate cancer. Just six days later, James ...
"It’s crucial that patients and their families know about this new option," said Dr. William Russell, an oncology radiologist ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback